The biodistribution and imaging of 16 α-[18F]fluoroestradiol (18F-FES) in rats and breast tumor-bearing nude mice

Zhong-yi YANG,Ming-wei WANG,Yong-ping ZHANG,Jun-yan XU,Hui-yu YUAN,Ying-jian ZHANG

2011-01-01

Abstract:Objective 16α-[18F]fluoroestradiol(18F-FES) is an in vivo specific imaging agent for ER(estrogen receptor).It could help clinicians to apply individual endocrine therapy in patients with breast cancer.We investigated the biodistribution of 18F-FES in rats and breast tumor-bearing nude mice,and we performed animal PET/CT in tumor-bearing nude mice.These could be necessary for further clinical research.Methods 18F-FES was prepared ourselves.The biodistribution of 18F-FES in immature female rats was determined.We used human ER positive(MCF-7) and ER negative(MDA-MB-231) breast cancer cell lines to construct tumor models in nude mice.The uptake of 18F-FES in ER positive and negative breast tumor models was observed as well.We performed animal PET/CT in tumor-bearing nude mice.Results The 18F-FES uptake by uterus and ovary,an ER-positive tissue,was higher than by lung and spleen in rats.(At 2h,the ID/g% of uterus,ovary,liver,kidney,lung,spleen and blood was 3.74±1.33,1.00±0.39,0.97±0.19,1.10±0.25,0.30±0.07,0.23±0.09 and 0.6±0.18,respectively).Both data in biodistribution and imaging demonstrated that the 18F-FES uptake in tumor site was obviously higher in ER positive breast tumor models than in ER negative ones.Conclusion These results suggested that the distribution of 18F-FES in tissues is associated with ER,thus it may be useful for studying breast or other cancers in observing ER expression and guiding individual therapy.